Roller, Devin G <br/><br/>
Synthetic lethal screening with small-molecule inhibitors provides a pathway to rational combination therapies for melanoma.  [electronic resource] 

 -  Molecular cancer therapeutics  Nov 2012 
 - 2505-15 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-12-0461  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--analysis<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Cell Death--drug effects<br/>Cell Line, Tumor<br/>Diclofenac--pharmacology<br/>Drug Synergism<br/>Extracellular Signal-Regulated MAP Kinases--antagonists & inhibitors<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Genome, Human--genetics<br/>Humans<br/>Melanoma--drug therapy<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--pharmacology<br/>Phospholipases A2, Cytosolic--metabolism<br/>Signal Transduction--drug effects<br/>Skin Neoplasms--drug therapy<br/>Small Molecule Libraries--analysis<br/>Sorafenib